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Future Opportunities for IoT to Support People with 
Parkinson’s  
 
ABSTRACT 
Recent years have seen an explosion of internet of things 
(IoT) technologies being released to the market. There has 
also been an emerging interest in the potentials of IoT 
devices to support people with chronic health conditions. In 
this paper, we describe the results of engagements to scope 
the future potentials of IoT for supporting people with 
Parkinson’s. We ran a 2-day multi-disciplinary event with 
professionals with expertise in Parkinson’s and IoT, to 
explore the opportunities, challenges and benefits. We then 
ran 4 workshops, engaging 13 people with Parkinson’s and 
caregivers, to scope out the needs, values and desires that the 
community has for utilizing IoT to monitor their symptoms. 
This work contributes a set of considerations for future IoT 
solutions that might support people with Parkinson’s in 
better understanding their condition, through the provision of 
objective measurements that correspond to their, currently 
unmeasured, subjective experiences. 
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INTRODUCTION 
Parkinson’s is a progressive neurological condition, 
which is thought to affect anywhere up to 10 million 
people worldwide [4]. The likelihood of receiving a 
diagnosis of Parkinson’s increases with age, thus the 
Parkinson’s community is largely made up of people 
over 65 [59]. It is caused by a depletion of dopamine in 
the brain—which regulates movement and emotional 
response [63]—although the reasons for why this 
happens are still not clear [50]. Parkinson’s is classified 
as a movement disorder, primarily characterized by 
three main symptoms [14]: 1) tremor, which is often 
seen as shaking of the hands; 2) rigidity, causing stiff 
and inflexible muscles which can affect activities such 
as getting out of bed in the morning, or dexterity during 
dressing; and 3) slowness of movement, which can 
cause a delay in the initiation of movements, such as 
swallowing food or walking. There are also a multitude 
of non-motor symptoms (e.g. pain, fatigue, anxiety and 
depression), which can further complicate the 
experience of living with the condition [46].  
Previous research has explored the potential for using 
technology to help people with Parkinson’s monitor and 
manage their symptoms [2, 3, 8, 11, 26-31]; from 
wearable devices to support freezing episodes [3, 7, 26], 
speech [30, 31], and drooling [29]; to gaming systems to 
support motor rehabilitation [2, 28]. These types of 
technologies offer individuals an opportunity to gain a 
better understanding of their condition and how to 
manage it effectively, and ultimately regain a sense of 
control over their lives [15].  However, to date, literature 
has largely focused on single platform data collection 
tools (e.g. mobile/ wearable), which provide information 
about limited aspects of Parkinson’s and thus do not 
capture the complexity of the condition, in part due to 
the heterogenicity of symptoms that make the condition 
so idiosyncratic 
In addition, there are acknowledged challenges [29, 32] 
with these technologies (e.g. a lack of fine motor skills 
to manipulate small buttons or touch screen interfaces) 
which can make them less accessible to the wider 
Parkinson’s community. A recent paper by Vega et al. 
[79] further discusses the need for tools which support 
people with Parkinson’s to self-report their symptoms to 
be ‘frictionless’ (in that users should not have to perform 
actions that might make self-reporting feel like a chore) 
when considering long-term engagement in practices 
that require direct user input. With the rise in available 
connected devices on the market which have the 
potential to collect health data, often passively without 
any need for user input, there are multiple opportunities 
to overcome these issues with accessibility and rethink 
the way we consider user generated data collection. 
In this paper, we describe a series of engagements to 
scope the future potentials for Internet of Things (IoT) 
based technologies to support people with Parkinson’s. 
We first ran a 2-day multi-disciplinary event with 23 
professionals, with expertise and interest in Parkinson’s 
and/or IoT, to explore the opportunities, challenges and 
benefits that connected devices might have for people 
with Parkinson’s. Second, we ran 4 workshops, 
engaging 13 people with Parkinson’s and caregivers, to 
scope out the specific needs, values and desires that the 
Parkinson’s community might have in terms of utilizing 
IoT technologies to support their health. Our work 
showed a surprising existing level of engagement and 
interest in current IoT technologies from the Parkinson’s 
Permission to make digital or hard copies of all or part of this work for personal or 
classroom use is granted without fee provided that copies are not made or distributed 
for profit or commercial advantage and that copies bear this notice and the full citation 
on the first page. Copyrights for components of this work owned by others than ACM 
must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, 
to post on servers or to redistribute to lists, requires prior specific permission and/or a 
fee. Request permissions from Permissions@acm.org. 
CHI 2020, April 25–30, 2020, Honolulu, HI, USA. 
© 2020 Copyright is held by the owner/author(s). Publication rights licensed to 
ACM.  ACM ISBN 978-1-4503-6708-0/20/04...$15.00. 
DOI: https://doi.org/10.1145/3313831.XXXXXXX 
 *update the above block and DOI per your rightsreview confirmation (provided after acceptance) 
 2 
community, and highlights a culture of self-
experimentation that is currently ongoing, which could 
provide an interesting opportunity for further research. 
Through this work, we contribute a set of design 
considerations for future IoT solutions that might 
support people with Parkinson’s in building a better 
understanding of their condition, through the provision 
of objective measurements that correspond to their, 
currently unmeasured, subjective experiences.  
BACKGROUND 
Clinical Measurement of Parkinson’s 
Of the tools used within clinical practice to diagnose, and 
measure the progression and impact of Parkinson’s 
symptoms, the most widely recognized is the Unified 
Parkinson’s Disease Rating Scale (UPDRS) [21]. This tool 
compiles a series of clinician (clinical assessment and 
interview) and patient (questionnaire) rated items on a scale 
of 0-4, providing an overview of severity and impact. Whilst 
widely revered as the most comprehensive assessment for 
measuring Parkinson’s, the approach itself is subjective, 
resulting in issues with accuracy and consistency [61]. 
In addition, clinical assessments tend to be measured over a 
short duration (e.g. questions ask responders to discuss their 
symptoms “over the past week”) and infrequently, capturing 
only a brief snapshot of the condition within a consultation 
period (which typically lasts no more than 30 minutes every 
6-12 months) [40]. The challenge with this, is that the 
severity of Parkinson’s symptoms can fluctuate hugely, over 
weeks, days, and even hours [52]. As such, building a true 
picture of an individual’s condition, and its impact on their 
life, can be difficult. These issues are further exacerbated 
through the use of low-resolution scales, which may mask or 
accentuate small changes in symptom severity [61].  
The close monitoring of Parkinson’s symptoms is essential 
to maximize and prolong quality of life [78], with the added 
complexity that the extended use of Parkinson’s medications 
can cause additional side effects such as ‘off periods’ (where 
symptoms can switch dramatically from being well 
controlled to be uncontrolled, often likened to the ‘flicking 
of a switch’) and dyskinesia (involuntary and uncontrollable 
movements e.g. jerking; writhing) [49].  
Technology-Based Approaches  
In an attempt to address some of the aforementioned issues, 
research exploring the use of technology to improve 
symptom monitoring has emerged. One strand of this work 
has focused on the detection of Parkinson’s symptoms such 
as freezing [26, 75], and tremor and dyskinesias [18], 
through wearable devices—typically utilizing inertial 
sensors such as accelerometers and gyroscopes to determine 
movement of the trunk and limbs. Similarly, several 
researchers have used smartwatches to generate time-based 
estimates of bradykinesia (slowness of movement) during 
daily activities [54], to support the differential diagnosis of 
Parkinson’s tremor against other types of tremor during daily 
activities [37], and to improve medication regimes [20].  
More recently, literature has emerged exploring the potential 
for smartphones—powerful multi-sensor platforms, now 
ubiquitous in our society—to assess and continuously 
monitor Parkinson’s. Several researchers have focused on 
analyzing mobile interactions as an approach to unobtrusive 
symptom monitoring [1, 19, 79, 83]. For example, 
Aghanavesi et al. [1] used touch screen interactions to 
quantify changes in manual dexterity over time. Vega et al 
[79] also discuss using a mobile based approach, combining 
the medical literature, location and activity recognition data 
to create a set of personal predictions with the potential to 
track symptom fluctuations around an individual with 
Parkinson’s. This allowed inferences to be made around 
mood, symptom severity and ability to perform everyday 
activities when changes in this profile of living are detected. 
Finally, Zhan et al. [83] developed a mobile based 
assessment tool, implementing machine learning techniques, 
to quantify Parkinson’s symptom severity, which directly 
correlated with UPDRS scores, providing a promising 
solution to the issues of scoring inaccuracy that we have 
already discussed.  
Finally, there are many examples of bespoke or re-purposed 
off-the-shelf devices being used to detect and monitor 
Parkinson’s. These include the Microsoft Kinect, which has 
been used for the analysis of impaired speech [5] and gait 
[16]; the Nintendo Wii for quantification of tremor [71]; and 
finally, the Google Glass [31] which has been used to provide 
a continuous monitor of speech volume during conversation.   
Despite the significant amount of progress made within the 
area of technology-based assessment of Parkinson’s, the 
majority of examples focus on either worn, or carried, 
devices, and often only give an indication of one symptom. 
In acknowledgement of the multi-faceted nature of the 
condition, there is real opportunity for approaches that utilize 
multiple data flows [79, 80] and sensor technologies to paint 
a full picture of the complexities of living with Parkinson’s, 
to better inform care provision, and personal understanding 
of the condition. 
Monitoring Chronic Health Conditions through the IoT 
The term ‘Internet of Things’ (IoT) has come to describe a 
network of physical objects that connect and exchange data 
[81]. Previously non-digital objects can now be augmented 
with sensors with the ability to collect, and transfer data, 
enabling us to make sense of their use within daily life. With 
estimates that the number of Internet connected devices will 
likely reach 50 billion by 2020 [17], the potentials for 
utilizing the IoT to help us understand health are unbounded.   
In particular, recent years have seen the emergence of 
literature exploring how IoT devices can support the 
monitoring of symptoms related to chronic health conditions. 
Diabetes is one area which has received attention [55, 10, 12, 
23]. For example, Rahman et al. [55] discuss the 
development of a non-invasive IoT breath test, which can 
monitor complications of diabetes. Chang et al. [10] also 
discuss a blood glucose monitoring system that interacts with 
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a phone to send users reminders to change their dietary 
behavior. The potential for supporting people with 
respiratory conditions, such as asthma and COPD, have also 
been studied including; wireless body-worn sensors, 
measuring factors such as a heart rate, blood pressure, and 
oxygen saturation levels [13, 57]; and environmental sensors 
measuring air humidity, and temperature [13] and air quality 
[44]. Finally, connected pill boxes have the potential to 
support medication adherence for a range of conditions, by 
providing relevant reminders that go beyond traditional pre-
set alarms [65, 83].   
Within the space of monitoring Parkinson’s symptoms, there 
have been several papers which have explored how IoT 
technologies might be implemented to gain an understanding 
of the condition [24, 51, 34]. For example, Memedi et al. [34] 
discussed the highly comprehensive design of an interface, 
which visualized symptom and medication information on a 
tablet app, for users with Parkinson’s, and a web app for 
clinicians. Data was collected and integrated through a set of 
commercial IoT devices: a wrist worn sensor, developed by 
Global Kinetics [20], which provides measures of tremor, 
slowness of movement and dyskinesias;  a medication dosing 
device, developed by Sensidose [64], which dispenses 
correct doses of medication based on schedules defined by 
clinicians; and a bed sensor, developed by Cenvigo [9], 
which captures data about sleep patterns. The authors also 
collected data on self-reported physical activity and meal 
intake times through a smartphone application. Whilst the 
authors found that people with Parkinson’s were enthusiastic 
about learning more about their condition, they highlight a 
further need to consider the discrete individual 
characteristics of each user. Similar to [79], the authors also 
discuss the need to ensure that future systems do not place 
too much of a burden on users, whose physical symptoms 
and unfamiliarity with certain modern technologies can 
cause stress and fatigue during early adoption.  
Whilst this research provides exciting insight into what a real 
IoT based system to support Parkinson’s care might look 
like, the authors’ focus was on interface design, integrating 
data streams from several pre-decided, specialist devices. 
Even in the early stages, participants expressed a desire to 
monitor more than just the aspects reported, with final 
findings showing that additional participants had further self-
monitoring needs, a finding also echoed by [79]. This again 
highlights the heterogeneous and complex nature of 
Parkinson’s and calls for research which explores 
approaches to the design of systems that take these 
considerations into account.  
In an attempt to address this gap in the literature we took a 
participatory approach to understand the overarching 
opportunities, challenges and benefits that IoT solutions for 
Parkinson’s might provide. We scoped both wider 
professional opportunities, as well as the intrinsic 
motivations and desires for self-monitoring that people with 
Parkinson’s had. Our work yielded insights into a culture of 
existing self-experimentation and IoT device use in the 
Parkinson’s community, which could be leveraged for future 
work. Our study was conducted in two stages. The first 
sought to gain an overarching understanding of the shared 
interests that different professionals might have when 
thinking about future opportunities for IoT to support 
Parkinson’s. Through a 2-day multidisciplinary workshop, 
we conducted a series of targeted activities aiming to drive 
forward future directions for research and practice in 
Parkinson’s care delivery. Attendees came from a range of 
disciplines, thus we were attempting to explore key 
multidisciplinary opportunities and challenges. The second 
stage of the work involved unpicking some of these key 
challenges and opportunities with the Parkinson’s 
community, by gaining an understanding of their data needs, 
and how engagement with IoT technologies might feasibly 
fit into their already complex lives.  
STAGE 1: APPROACH 
In order to begin our exploration, we held a 2 day workshop 
at Blind University with 23 professional delegates from a 
range of disciplines; including clinical practice (n=2), health 
research (n=3), sociology (n=1), engineering (n=3), design 
(n=3), and HCI (n=7). We also had representatives from a 
leading Parkinson’s charity (n=2)—a staff member who 
worked in the involvement and inclusion team, and a person 
with Parkinson’s—and a representative from industry (n=1).   
Attendees were invited to the workshop via an open email 
call for participation, extended to personal and professional 
contacts and mailing lists that the research team had, as well 
as then being snowballed to a wider network of contacts. 
Potential attendees were asked to register their interest via 
email, providing a brief description of their area of expertise, 
their experiences of Parkinson’s, and their interest in IoT (to 
allow us to best plan the structure of the event).  
Multidisciplinary Professionals Workshop 
Workshop activities were held between 10:30 and 17:00 on 
day 1, and 9:30 and 16:00 on day 2. Both days were 
structured to include a morning session made up of short 
talks (to provoke interest around a range of topics), and 
afternoon sessions made up of collaborative activities (to 
develop shared areas of interest and explore potential IoT 
solutions).  Talks were provided by a selection of workshop 
attendees and lasted no longer than 15 minutes each. Topics 
covered: Parkinson’s and its physical and psychological 
symptoms; current state of the art around monitoring 
Parkinson’s symptoms using mobile and wearable 
technology; current and future opportunities for digital 
health in industry; Ethical issues around assistive 
technologies; and challenges with IoT adoption.  
On day 1, the afternoon session started with a scoping 
activity, which asked attendees to work in small groups of 
between 4 and 6 (denoted in the findings as ‘GroupX’; n=4). 
Each group contained at least 1 attendee with clinical 
expertise in Parkinson’s), to scope and discuss examples of 
IoT devices for healthcare and consider the types of devices 
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that they might envision being useful for people with 
Parkinson’s. This activity was facilitated by a booklet 
depicting images and short descriptions of a selection of IoT 
products (e.g. heart and respiration monitor, smart home 
light and temperature control, home energy use sensors, 
ingestible pill sensors, biometric sensors, connected pill 
boxes). We asked the groups to brainstorm the types of 
symptoms, settings and opportunities they could envision 
IoT being used to support tracking for Parkinson’s.       
The facilitators then developed 4 themes to further explore, 
based on the discussion points that were emerging. Attendees 
were asked to join a table with a theme they found most 
interesting and quickly brainstorm the types of IoT devices 
that might be useful to someone with Parkinson’s within 
each theme. They were then asked to extend these initial 
ideas using Osborne’s checklist of manual thinking for idea 
generation [45], which supports users to modify, magnify, 
minimize, substitute, rearrange and combine their ideas to 
provoke creativity and a new way of thinking.  
The afternoon sessions on day 2 focused more on applying 
the broad ideas we had formulated on the first day to specific 
Parkinson’s cases, in an attempt to further explore the 
feasibility that our ideas might have within the complex 
everyday lives of people experiencing Parkinson’s. We first 
played participants a set of videos of people with Parkinson’s 
sharing stories of their lived experience (videos depicted 
various symptoms, severities, home lives and priorities; a 
person with very severe movement symptoms (created with 
permission for the workshop), a younger person with a small 
child [48], and a person who had just returned to work [47]). 
We asked attendees to focus on a specific case study, 
considering the needs of the person, and brainstorm ideas for 
a bespoke IoT solution that might be suitable. Finally, we 
asked attendees to, in pairs or threes (denoted in the findings 
as ‘PairX’; n=8), discuss some of the challenges and benefits 
of their ideas for supporting Parkinson’s, and how these 
might be avoided and achieved respectively. Attendees were 
given a worksheet to conduct this activity on (see figure 1).  
Both days of the workshop were photographically 
documented. In addition, the collaborative afternoon 
sessions were documented by each group on paper, with 
whole group discussions being further documented through 
note-taking by the facilitators. All paper data was analyzed 
using a top down thematic analysis approach, in that we were 
specifically focused on understanding the overall 
opportunities, challenges and benefits of IoT solutions for 
Parkinson’s care, identified throughout the workshop. This 
allowed us to gain a broad overview of what attendees felt 
was most important for future researchers to consider. 
STAGE 1: FINDINGS 
Scoping opportunities for Parkinson’s  
Our first activities focused on scoping the current state of the 
art in commercial IoT and beginning to understand how IoT 
technologies might be of use to people with Parkinson’s. The 
attendees first discussed, more broadly, the range of 
Parkinson’s symptoms that might be able to yield data from 
an IoT device. They discussed these symptoms across 4 
broad categories; 1) Motor, or movement, related symptoms 
(e.g. tremor, rigidity freezing of gait, issues with balance); 2) 
cognitive symptoms (issues with memory, attention, or 
language); 3) psycho-social symptoms (isolation, 
depression); and 4) other non-motor symptoms 
(constipation, loss of smell, insomnia). 
In their groups, attendees then moved to discuss a range of 
settings and opportunities to further explore. Perhaps 
unsurprisingly, due to the nature of Parkinson’s as a motor 
condition, the majority of discussion centered around sensor-
based tracking of movement symptoms (Groups 1-4). In 
particular, how this could then support assessment of 
symptom severity to facilitate early diagnosis (Groups 1-4), 
assess medication benefits (Group 1, Group 4), and track the 
ongoing progression of the disease (Group 1, Group 3). 
Further discussion focused on improving motor symptoms, 
through cueing (Group 1), adaptations to medication (Group 
1, Groups 3-4), and helping with freezing (Groups 3-4).  
Attendees then moved to discuss the potential for multiple 
technologies both within the person’s home, and local 
community, to help track mental state and social interaction. 
For example, by correlating emotional state to motor 
symptoms (Group 2), and tracking contact with other people 
(Group 1). This sense of connectedness with others was 
linked to having ‘Parkinson’s friendly spaces’ in the local 
communities to help, as well as being able to call for help if 
needed, e.g. through a voice assistant, or automatically 
through a falls alarm (Group 1). 
Finally, there was discussion around the need for future 
technologies to be adaptive to self-monitoring/management 
approaches as the condition progresses (or indeed 
degenerates), i.e. evolving to needs as they change over time 
(Group 2, Group 4) and encouraging the person to self-care 
as their needs change, through positive reinforcement or 
nudges (particularly for those with apathy or low motivation 
(Group 3)). In addition, the need for personalization of 
Figure 1: Paper-based activity in multi-disciplinary workshop 
 5 
technology solutions was highlighted, as the most important 
symptom is often different for individuals (Group 3).  
Envisioning future IoT solutions for Parkinson’s 
The range of potential opportunities for IoT to support 
people with Parkinson’s was seen to be beneficial in a 
multitude of ways; supporting people to monitor their health 
and medication regimes (Pair 3), improve quality of life (Pair 
4), retain a sense of independence and autonomy (Pair 1, 
Pairs 7-8), and regain a feeling of increased control over 
one’s health condition (Pairs 2&4). However, attendees also 
discussed challenges to fully envisioning these opportunities.  
The first set of challenges to arise related to the robustness 
of any future IoT devices, particularly when dealing with a 
highly heterogeneous group such as people with Parkinson’s 
(e.g. “inaccuracy in measurements” (Pair 1); “reliability of 
the device” (Pair 1); variable “data quality” (Pairs 5-6)). 
Suggestions to overcome these issues involved using “larger 
numbers of sensors” (Pair 1) to build a bigger picture of the 
person (which was also seen as a big benefit by Pair 1 and 
Pair 5); and using existing commercial technologies (Pairs 5-
6) to improve general robustness of the technology and “fast-
track scalability of the research” (Pair 5). Cost (Pair 2, Pairs 
4-6) also arose as a potential barrier to adoption, however the 
suggestion to “integrate future solutions with existing 
devices” might overcome this issue (Pair 7), in addition to 
becoming a possible way to overcome the issue of device 
obtrusiveness (Pairs 1&3), particularly in relation to the 
visibility of future solutions (i.e. of worn devices) and their 
potential to stigmatize users (Pairs 6-8). 
There was a theme of discussion around power dynamics 
between a clinician and patient and how, at times, the 
consultation process can be a de-powering experience for the 
patient, if they feel they do not have control in leading 
discussions about their own health (Pairs 2&4). Having the 
ability to share data with a clinician before a consultation was 
seen as a useful way to regain a sense of power (Pairs 2&6) 
and improve interactions between the patient and doctor, to 
improve personalization of care plans (Pairs 4&6). As such, 
ensuring patients have control over their own data (Pair 2, 
Pair 7), maintain a feeling that their data is secure (Pair 5), 
and feel that they have consented to what data is collected 
about them (Pairs 5-7) was also seen to be of high 
importance. Pair 7 expanded this to discuss the need for 
“clearly defined pathways around what data will be used for. 
Consider holding data ‘on the edge [i.e. locally on the 
device]’ as opposed to in the cloud” to enhance a feeling of 
data security.  
The final theme of discussion centered around the need to 
create bespoke solutions that were mindful of the 
personalized needs of the individual (Pairs 3-4, Pairs 6-8), 
and how this in itself could be challenging for future 
researchers dealing with a “diversity of data” (Pair 7), which 
is then “difficult to generalize to a larger population” (Pair 
6). In addition, the need for technologies to be usable, 
specifically to the needs of people with Parkinson’s, was a 
further challenge (Pairs 3-4), with Pair 4 giving the example 
that “voice recognition could be a difficulty” as an input 
modality (yet at the same time overcomes some of the issues 
around manual dexterity that people with Parkinson’s can 
experience). Seen to be most vital for overcoming this issue 
was involving a range of stakeholders in the design process, 
to understand usability and data needs, rather than taking a 
techno-centric approach (Pairs 3-5). 
STAGE 2: APPROACH   
The next stage of our work involved conducting a series of 4 
workshops with people with Parkinson’s and their caregivers 
(n=13), to begin to gain an understanding of the types of data 
they would like to have to help support them in the 
monitoring and management of their condition, and how 
different types of IoT technology might fit into their lives. 
Each workshop lasted 3 hours and was held at various 
locations across Blind for Review.  
Participants were recruited into the study through an open 
call for participation, which was distributed via email 
through Parkinson’s charity. A total of 26 people registered 
their interest and were sent further information. Of those, 18 
responded to say they would like to take part in a workshop, 
however only 13 were able to make the dates and times 
suggested. Table 1 provides a summary of participant details.   
Workshops with people with Parkinson’s 
Each workshop followed a similar format but remained fluid 
enough to allow for ebbs and flows in discussion, and 
variations in the group’s needs [28]. We began each 
workshop with an open discussion around each person’s 
experience of Parkinson’s, their interest in the research topic 
and their general experiences with technology. We then 
asked participants to complete a brief priority setting activity 
to help look for overlapping concerns and ultimately add 
focus to the following activities. Participants were asked to 
look through a set of 10 priority areas for research (balance 
and falls, stress and anxiety, uncontrollable movements, 
personalized treatments, dementia, mild thinking and 
Table 1: Summary of participants (Number refers to 
participant number, with C denoting carers; YSD refers to 
years since diagnosis) 
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memory problems, monitoring symptoms, sleep, dexterity, 
urinary problems), developed with over 1,000 people with 
Parkinson’s, carers and health and social care professionals 
[43]). We asked them to place a colored dot on the 3 priorities 
they felt most concerned about, and then discuss their 
number 1 concern with the group. 
The second activity then involved creating a timeline of the 
groups’ typical day. Participants were asked to, on post-it 
notes, write the typical things they do day-to-day and place 
them on a large timeline (with hours of the day on the x-axis, 
and a rating of how challenging it is for them on the y-axis. 
See figure 2). Participants were asked to think about whether 
there was anything they felt would make their day-to-day 
lives easier, and the types of information they would need to 
better understand their challenging symptoms or activities. 
Participants were then probed about what they would like to 
know more about, what this knowledge would then enable 
them to do, who they would want to share this information 
with, and the technology they could envision using.  
Each workshop was audio recorded and transcribed verbatim 
for later analysis, yielding 12 hours of transcribed audio data 
in total. Four members of the research team analyzed the data 
independently, conducting an inductive thematic analysis on 
the transcripts [7]. Data was coded at the sentence to 
paragraph level using short labels. These were then grouped 
together, to construct of 23 themes that captured the core 
topics and concerns from the data. These themes were then 
synthesized into the 5 broader theme headings that we used 
to explicate our findings; Understanding the day-to-day 
challenges of Parkinson’s; Maintaining physical activity; the 
emotional toll of Parkinson’s; Tracking the impact of non-
clinical interventions; and Current use of IoT technologies.  
 
STAGE 2: FINDINGS 
Understanding the day-to-day challenges of Parkinson’s  
Participants described a wide range of physical symptoms 
that they experienced (see table 1). Several also discussed co-
morbidities that they had to contend with, often seen to lead 
to confusion over whether “the symptoms could be 
something else not Parkinson’s” (P13). In particular, the 
often unpredictable nature of symptoms was seen to cause 
difficulties “you get days where you just shake the whole 
day…and the next day it’s different again” (P8).  
Participants found it difficult to find consistent information 
about Parkinson’s because “it affects people differently” 
(P11). This led to confusion and worry when reading more 
generic information “I don’t want to read any more about it. 
It starts making you think ‘have I got that?’” (P12). This was 
not helped by the fact that participants often saw different 
clinicians during their regular assessments. For example, P8 
described: “if you see somebody different, they don’t really 
know [you]”. There was a sense that measurements collected 
by clinical staff were largely ‘subjective’: “they say ‘oh yes 
this is a bit worse, or this is different’” (P10) and it was 
difficult for participants themselves to equate clinical 
assessment to the way they felt “sometimes [nurse] will say 
‘I've noticed a deterioration there’ …I might not feel it 
sometimes” (P8). Participants expressed a desire for: “a 
more objective assessment… feel that when you saw the 
neurologist that your actually getting facts rather than what 
you feel on the day” (P9). 
Remembering to take medication was highlighted as one of 
the most common issues that participants wanted support 
with (P2, 3, 5, 6, 9, 11, 12). P12 described, “it’s trying to fit 
my tablets in with what I’m doing…I’ve got such a busy life 
I tend to forget”. For P5, concern over sticking rigidly to 
their medication regime led them to avoid leaving the house 
for portions of the day: “At the moment all my medication is 
taken in the morning, so I don’t go anywhere. Once it has got 
to be taken in the middle of the day I know I am going to get 
paranoid about that”. Diet was seen to be a cause of 
confusion when it came to taking medication. P8 described, 
“if you have a lot of protein it’s not effective, one works 
against the other, so you have to have it an hour before your 
food or sometime later”. P12 echoed this: “I’ve got to have 
it on an empty stomach its ok in the morning but much more 
difficult at lunch and tea time”. Participants expressed a 
desire to be able to monitor their medication, and its effects 
on their symptoms, more effectively in order to improve their 
understanding of the optimal mediation cycle for them: “you 
may forget maybe an hour later in the day, may be 2 hours 
or you might miss a dose, how does that effect your 
movements?” (P11). For P9, this was seen to be important as 
they did not always display worsened symptoms as a result 
of forgetting: “If I forget [medication] I don’t freeze like with 
some people. So, having some knowledge to how things are 
going and how you’re doing is really quite important” (P9). 
Being self-aware was seen to be a positive factor for 
retaining a sense of control “I think being self-aware 
knowing what’s going on has helped me enormously” (P2). 
P6 echoed this sentiment: “I think it’s easier to live your life 
with knowledge about your condition … to not be told 
anything about your condition or to not have knowledge 
doesn’t lead to good psychological care”. 
Tracking the Impact of Non-Clinical Interventions 
Figure 2: Timelining activity within Parkinson's workshops 
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Participants expressed a desire to understand how non-
medical, or self-directed, ‘interventions’ they were currently 
conducting on themselves (e.g. changes in exercise, changes 
to diet) were making a difference to symptoms. For example, 
P11 wanted to understand “see some correlation between 
what exercise you done that day and how you feel at different 
points during the day”.  
As can be seen from the visual example in figure 2, 
participants led extremely physically active lives day-to-day. 
They reported conducting a range of activities, including but 
not limited to, playing football (P1, 12), running (P2), 
walking regularly (P5, 10, 13), hiking (P6), doing exercise 
videos at home (P3, 13), attending the gym (P1, 11, 13), and 
doing yoga and reiki (P2). Participants discussed the need to 
maintain a ‘use it or lose it’ (P2, 6, 8) attitude in order to 
ensure that skills are not lost as Parkinson’s progresses. It 
was clear that participants received great amounts of pleasure 
and a sense of achievement when completing their activity 
goals. For some, this was more about hitting targets like “as 
long as I’ve done my 10,000 steps” (P13), where for others it 
was seen as an important way to manage their symptoms. For 
example, P2 described: “I do reiki and that is brilliant it’s 
like a Parkinson’s holiday, its wonderful for the tremor. I’ve 
been in some days and I have had a really bad tremor and it 
just goes”. However, for some keeping active was at times 
challenging and unpleasant, although necessary: “It’s very, 
very hard to keep physically active when legs won’t go where 
you think…[I do] At least 20 minutes a day and it’s an 
unpleasant experience” (P10).  
Participants also discussed a range of interesting dietary 
changes that they were trying in an attempt to improve their 
symptoms, based on articles they had read online, or things 
they had heard from friends. For example, P1 discussed 
eating red peanuts as “they are good for motorization”, 
while P10 discussed eating melon as a way to help 
medication absorption: “I’ve been on the melon diet…the 
ability for your stomach to absorb [medication] and for 
that getting into the bloodstream and therefore ending up 
in the brain”. P9 discussed how they had been eating 
Marmite, a savory spread made from yeast abstract, for a 
similar reason: “There was something recently about 
Marmite being good for neurological conditions…  I'm not 
a great fan of Marmite but I’ll have Marmite on toast 
maybe 3 or 4 times a week”. Finally P8, discussed taking a 
turmeric extract powder twice a day for a month, and how 
her partner felt that he noticed a difference, “He thinks that 
I've been walking better with this… he doesn’t think my 
tremor’s as bad, I haven’t really noticed anything but he 
watches me at night”. 
Whilst participants were willing to try many new things, their 
basis for continuing with them was largely subjective; they 
did not currently have a systematic way to track if said 
‘intervention’ was making an objective difference to their 
symptoms. P5 and P8 discussed keeping notes about their 
symptoms, however these were seen to have drawbacks; “I 
try to write notes as I'm going along… but I forget, and when 
it’s time to see [clinician] you’re wondering well, what did I 
feel? and when did I feel I t?” (P8). Improving this process, 
by adding objectivity to monitoring techniques, was 
discussed as a real opportunity for technology. Firstly, in 
informing personal understanding of Parkinson’s. P5 
explained, “I know my body and mind are changing but I 
don’t understand why, which causes me to fret sometimes”, 
where P10 described: “We’re not the best judge ourselves in 
some ways because you tend to react to how you feel on the 
day…[I need] something which is monitoring that I might 
have had a bad night and woken up 3 or 4 times”.  
Second, there was seen to be benefit in improving 
conversations with clinicians to better inform care, “if you 
were monitoring [rigidity over time] and you could see there 
a difference then you could tell your neurologist or 
Parkinson nurse” (P8). However, despite participants 
enthusiasm around using technology to support self-
monitoring, when asked if participants would be willing to 
‘log’ data—in the sense of opening an application and typing 
in aspects such as food intake, or symptoms—participants 
were wary of the effort that this would take. P1 discussed 
how typing can become challenging if fatigued, “If it is 
ticking boxes then yes, but if it is typing then that’s a pain 
because it depends what you have done that day”. P11 was 
similarly concerned over the level of ‘effort’ that detailed 
self-report might entail: “there’s a lot of effort required to do 
that, if it can be made simple to input then fine, but counting 
the carbs and calories is again quite difficult” (P11). 
However, P3 suggested a workaround for this might be to 
use voice as an input modality: “speech recognition, I would 
find it a lot easier to do”. 
Current use of IoT technologies 
Our participants reported using a range of different 
technologies; smartphones (P5, 8, 9, 13), tablets (P3, 8, 9), 
wearables to track physical activity (P13), exercise games or 
online videos (P9, 13), cloud-based calendars (P5). All used 
computers for email and internet browsing. Several 
participants (P1, 8, 10) who were still at work also used the 
computer for office work, however reported challenges 
relating to time taken to complete tasks, fatiguing easily, and 
with manipulating the mouse and keyboard due to tremor: 
“The right hand is jiggling about and you’re hitting the 
mouse several times or you’re hitting keys constantly and 
misspelling words… it’s amazingly frustrating and hard to 
get the mouse to get into the right place” (P8). P1 and P10 
both had access to voice recognition software to support 
them with their computer-based activities in the workplace.  
Half of participants (n=6) were already using IoT 
technologies of some kind in their homes (e.g. Google home 
hub, smart meters). Voice assistants were most commonly 
discussed; in particular, Alexa (P1, 3, 4, 11-13), with P9 also 
using Siri regularly. Speech was one of the symptoms that 
several of these participants reported as an issue for them 
(P1, P3): “my speech is not as good as it used to be. I’m 
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speaking quite loud now, very loud for what I’m would 
normally speak, I do stammer” (P1), but this did not deter 
them from purchasing and trying out a voice assistant, with 
seeming success. When asked what he did if Alexa did not 
understand him, P3 simply said, “I try again a bit louder 
until she understands me”. Voice assistants were seen to 
particularly have potential as a system for providing 
reminders, e.g. “alarms for taking the tablets” (P3), or “you 
could you could get her to remind you to get out of your chair 
and stretch for 2 mins” (P2).  
It was clear that despite reporting some issues with setting 
these technologies up; “the trouble is using your fingers to 
start it up” (P9), participants appreciated the benefits smart 
technologies could bring. P12 described, “I got the Alexa 
and I’ve got all the lights on Alexa to turn on, so at night it 
comes on… I want to get it rigged up to the heating and 
different things…it’s a challenge for me I’m not really 
technical minded”. P11 felt more confident: “I’ve got the 
smart heating, just looking at some of the Google home or 
the Amazon echo and other devices, smart wireless, smart 
cookers, well you name it everything is going to be 
smart…anything that can make your life easier to control 
and give you information back about how much energy 
you’re using, what you’re doing in the house” 
Perceptions of Data Sharing  
As we were discussing many examples of commercial IoT 
technologies, and their potential for supporting the 
monitoring and management of Parkinson’s, it was important 
to acknowledge that data might be accessible to larger scale 
technology companies. As we develop application areas for 
new and emerging commercial technologies in the medical 
domain this is not a trivial issue, particularly when 
considering the duty of care we have to protect patient and 
participant data. Participants were mixed in their views about 
who they would be happy to share the data collected from 
IoT technologies with. For some it was clear that the benefit 
to others with Parkinson’s was a driver in their decision to 
share their data. P8 described: “I’d share the information 
with anybody if it helps people newly diagnose to cope…”; 
and P4 noted: “I’m quite happy for anybody who is doing 
Parkinson’s research or can help me with Parkinson’s or 
will have a better understanding of me. Let them all know”. 
P2 was more cautious but felt overall that the benefits 
outweighed the negatives: “It’s important to raise it to 
consciousness…but it’s for the greater good isn’t it”.  
Many of the participants discussed how aspects of their 
online lives were already being tracked and used by 
companies to personalize advertisements; something that 
was seen as a current norm: “You get it all the time with iPad. 
You look at some shoes and then 3 days later you get adverts 
for shoes. And you get things like that pinging at you all the 
time so we are used to that” (P1). P6 described: “They 
already know everything about us”, where P2 said: “We live 
in big brother at the end of the day”.  
However, when further probed, some had concerns about 
how unlimited access to their data might have an effect on 
their right to medical privacy: “would I tell the Doctor the 
truth about the amount I smoke and drink? No. I wouldn’t. I 
would lie every time, but if my watch is measuring it he would 
know without even asking….I’ve said yes go for it, but given 
chance to think about it then I would have a big list of things 
that I don’t want” (P4). One participant in particular was 
concerned about sharing with pharmaceutical companies 
who might make profit from their data “It should be free they 
shouldn’t make money out of it… I don’t want big 
pharmaceuticals to be involved” (P13). The discussion 
around this topic was mixed however, with several other 
participants highlighting the need for companies like this to 
have access to data in order to improve options for treating 
symptoms of Parkinson’s. For example, P11 described: “the 
medication has so many side effects, it could look at how to 
improve the drugs we already have”, where P4 said: “they 
live in a world where unless they can make a profit no one 
would make tablets”. 
However, participants had remaining concerns that other 
organizations, particularly those relating to their finances, 
might use their data maliciously: “The thing that would be 
bad about it is if it effected pensions and credit rating that’s 
when it gets toxic” (P2). This was seen to be the main worry 
that they had surround data use and sharing: “As long as it 
isn’t anything to do with banks. If its diet, exercise and 
everyday life that’s fine. But passwords and bank details 
that’s a no” (P1). Overall however, participants were largely 
happy to share their data with researchers, so long as they 
could be sure that it was been managed carefully and 
respectfully by the research team: “I think it’s the 
responsibility of the people running the research and then to 
disseminate that information to a wider field not to just have 
data blitzed around the internet there has to be a path to 
where to find the information before it’s published” (P12).  
DISCUSSION  
Through our work we have explored opportunities for IoT 
technologies to support people with Parkinson’s in 
understanding more about their condition; both as a way to 
regain a sense of control over their health, and to improve 
communication between the individual and clinical 
professionals, who often vary between visits. In the 
following, we synthesize our findings to reflect on 4 key 
opportunities for future research.  
Data Supported Decision Making in Care 
The IoT has undoubted potential to impact health service 
delivery [70] and the healthcare industry [57], by facilitating 
a new healthcare paradigm leading to more personalized, 
participatory, predictive and preventive health [62]. As the 
number of connected devices begins to rise [55], so then do 
the opportunities to implement them within health and care 
services. One particular area of interest is the potential for 
new data flows to augment clinical decision making [74, 6]. 
Our work highlighted several opportunities for supporting 
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the clinical assessment of Parkinson’s which, as we have 
discussed is currently conducted using subjective 
assessments which have low levels of resolution and are 
prone to cross-rater inaccuracies.  
The potential for technology to implement automated and 
continuous assessment, using environmental and body worn 
sensor systems, alongside machine learning approaches, has 
insurmountable potential for making this assessment process 
more objective. Indeed, previous work has already looked at 
improving this through the detection and classification of 
Parkinson’s symptoms using wearables [27, 75, 18, 54, 37] 
and mobile based assessment [79, 83]. This not only has 
impacts for our Western society, but also has the potential to 
improve this assessment process within lower income 
countries, where specialist services for conditions like 
Parkinson’s are only beginning to emerge [77].  
Our professional participants highlighted how the process of 
collecting data to discuss within clinical consultations can 
help an individual regain a sense of power and control during 
these clinical visits, by helping to open a line of 
communication through which to discuss care planning 
needs. In addition, our participants with Parkinson’s 
discussed the need for consistent measurement of their 
symptoms, particularly when seeing various different 
members of clinical staff who may, or may not, personally 
know them and how their Parkinson’s is progressing. Mentis 
et al. [35] describe the benefits of using Fitbit sensors to 
support the co-interpretation of movement data for people 
with Parkinson’s and their clinicians during clinical 
assessments. However, the authors highlighted how, despite 
the individual being involved in the creation and 
interpretation of the data, challenges around power dynamics 
remained. Future research should consider how promoting 
concepts of agency over one’s data, and the process of data 
generation and curation, might be able a useful was to tip the 
balance of power.      
Understanding Complex Symptoms  
Throughout our work, with both the professionals and our 
participants with Parkinson’s, there was much discussion 
around the need to acknowledge the complexity of 
Parkinson’s as a condition—and the highly heterogeneous 
nature of each person’s experiences, symptom profiles and 
the impact it has on their lives. Participants with Parkinson’s 
expressed a desire to have more than just a ‘snapshot’ view 
of their progression during clinical assessment. They wanted 
a way to identify patterns in their symptoms to better prepare 
for daily life. We acknowledge that this is not a novel finding 
in itself, this concept of complexity within Parkinson’s is 
heavily discussed in the literature [28, 79, 32-34, 41, 42]. For 
example, Nunes and Fitzpatrick [42] comprehensively 
described the complex processes that go into the everyday 
management of aspects of Parkinson’s. They describe the 
delicate negotiations and dynamic adaptions that individuals 
will make during their everyday self-care activities, calling 
for approaches for technology design that recognize the 
effort that it takes. However, our work adds to this body of 
literature by shining a light on the opportunities for IoT 
solutions which might support an enhanced understanding of 
these complex symptoms.  
Complex medication regimes, in particular those related to 
eating habits, caused much confusion for our participants. 
Future technologies that help users to build an understanding 
of how variations in in the way medication is taken (e.g. at 
the wrong time, with the wrong food), and how this then 
impacts symptoms, would be a valuable step towards 
enhancing people’s understanding of their condition. 
However, as discussed by [34], a focus on medication and its 
correlation with movement symptoms, while important, is 
not enough alone. There are many different factors which 
feed into having a good quality of life, so we also need to 
consider how to support observations around the multi-
faceted non-motor factors (which are as disabling as motor 
symptoms) that feed into this.  
Our work builds upon understanding into the messy lives of 
people with Parkinson’s, providing opportunities for how we 
might use technology to augment existing activities that 
people engage in, without becoming an added burden. Future 
work should consider how to develop highly personalizable 
systems that fit easily into the lives of the community, 
increasing the capacity for the delivery of personalized 
medicine. For example, one of the benefits of the IoT is the 
capability to instrument almost anything (e.g. a yoga mat, a 
dog’s leash). Future work considering the development of 
simple sensor systems that can provide custom data could 
offer a way for us to better understand the ‘mundane’ [42] 
aspects of daily life that people carry out, and the impact that 
these have on physical function and mental wellbeing.  
Opportunities to support Self-experimentation 
Our work highlighted several non-clinical interventions that 
participants currently engaged with in order to self-care. 
Where reports around the role of exercise, in improving 
control of movement and mental wellbeing, have been 
reported before [42], our participants also discussed 
experimenting with a range of pseudoscientific dietary 
‘interventions’. For example, one participant discussed 
eating Marmite daily, despite not enjoying the taste. The 
study on Marmite was reported widely in the press (e.g. 
[73]), hailed as a way to prevent neurological conditions such 
as dementia due to its high levels of vitamin B12. However, 
the study discussed was preliminary, looking at response 
rates to visual stimuli in 28 healthy subjects, and the theory 
has not yet been tested in people with neurological 
conditions [66]. Another participant discussed taking a 
turmeric extract powder [76] and reported that her partner 
had noticed a difference in her symptoms. Whilst curcumin 
(the active compound found in turmeric) has been showed to 
prevent neural degeneration and cognitive decline in mice, 
this theory has also not yet been tested on humans [39]. 
Participants’ willingness to try different things to improve 
their Parkinson’s could be due to the lack of information they 
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felt they had around their own condition. However, it could 
also be reflective of the time it takes to bring clinical 
evidence to the mainstream, and indeed the inaccessibility of 
clinical evidence (often reported in academic papers and 
disseminated through conferences) when it gets there (as 
discussed in [32]). Participants were willing to try a variety 
of new things to improve their condition, but their basis for 
continuing with these was largely subjective; they did not 
currently have a systematic way to track if said ‘intervention’ 
was making an objective difference to their symptoms, 
whether this be a placebo effect (actually shown to have a 
profound effect on relieving symptoms such as pain, fatigue 
and depression [38]) or otherwise. Future research might 
consider leveraging this self-experimentation culture; 
supporting people to improve the rigor of their practices and 
providing the objective measurements our participants so 
desired, to understand if lifestyle changes make a difference.  
Self-experimentation in its true form—described as an n=1 
experiment, or single case design, in which the individual 
serves as their own control to test their response to an 
intervention [58]—is an under-represented area of research 
within the field of digital health (although there are some 
broad scoping reviews of its use in social sciences [e.g. 60, 
67-69]). Karakar et al. [58] discuss the challenges with 
existing self-tracking technologies, in that they often don’t 
help the user to answer the specific question that led them to 
use the technology in the first place. They give the example 
of a user posing a question around caffeine intake and if it 
affects sleep. Whilst self-tracking technology may suggest an 
association, it never really gets to the bottom of whether the 
caffeine intake is due to the user’s tiredness, or if their 
tiredness is caused by lack of sleep due to caffeine intake. 
The authors propose a framework which supports people to 
identify variables, conduct experiments and move towards 
better informed behavior changes, and discuss an app to 
support the process. We believe that future work utilizing 
IoT could be a real benefit to supporting this process, by 
collecting automated data about multiple different variables, 
and reducing logging effort of the user [79, 35].  
Leveraging Current Technology Use 
We were interested to find that many of our participants were 
already using IoT technologies in their homes. Of course, our 
workshops were specifically on IoT for Parkinson’s, so it is 
possible we had a biased sample, but this observation 
somewhat counters a familiar narrative that we often see in 
research—that older adults, particularly those with 
accessibility issues, do not want to engage in new and 
emerging technologies. McNaney et al. [31, 33] similarly 
found that people with Parkinson’s had a willingness to 
engage in novel technologies to support their needs. 
Voice assistants, in particular Alexa, were discussed heavily 
among our participants. Despite acknowledged issues with 
speech, our participants were successfully using voice 
assistants, and with pleasure. One participant even reported 
modifying his speech patterns to improve the device’s ability 
to understand him. This echoes findings from Pradhan et al. 
[53] who conducted an analysis of reviews for the Amazon 
Echo (for which Alexa is the voice assistant) written by 
people with cognitive, sensory and physical disabilities. 
Users with speech impairments reported high levels of 
success when using the system, as well as describing how the 
device helped them to speak ‘slowly, loudly and clearly’. 
Speech and voice impairments are highly prevalent in people 
with Parkinson’s (approximately 90% will experience issues 
at some point in their condition [22]). Vocal loudness and 
increased rate of speech are particular contributing factors to 
the problem [36]. As such, understanding whether Alexa 
could help with treating speech and voice issues, or 
supporting a program of speech therapy, could be a valuable 
new avenue for research. It may even be possible that simply 
using Alexa as an ‘out of the box’ tool could have benefit. 
Our participants also discussed the possibility of using voice 
input as a way to collect self-report data. This in itself is a 
worthwhile consideration for future work exploring IoT 
solutions to support self-care. With acknowledged 
challenges around the burden that self-tracking can have on 
an individual [79, 34], particularly in the sense that physical 
symptoms and unfamiliarity with technology can cause 
stress and fatigue, voice input could offer a light-touch way 
to collect daily report data [25].   
However, it is important to note the potential challenges 
around data privacy and sharing when using commercial 
technologies within the healthcare domain. It is not always 
the case that researchers will be able to fully anonymize 
participants, or that healthcare workers will be able to control 
the storage of patient data in full accordance with healthcare 
data regulations. It is our view however, that this should not 
exclude the vast potential that these types of technologies 
might have in supporting patient care. As shown from our 
study, participants were happy to share their data for research 
purposes, and to benefit their care and the care of others. 
Their concerns lay in how their data might be used to affect 
their financial stability; a finding further echoed in [28]. As 
such, future work must be particularly careful to ensure that 
participants are made fully aware of the possible data sharing 
and ownership guidelines of commercial companies. 
CONCLUSIONS  
This paper has presented the findings of engagements to 
scope the future potentials of IoT for supporting people with 
Parkinson’s. This has led to four key considerations for 
future IoT solutions that might support people with 
Parkinson’s in better understanding their condition; data 
supported decision-making in care, understanding complex 
symptoms, opportunities to support self-experimentation and 
leveraging current technology use. Future research in IoT 
and Parkinson’s should focus on the development of sensor 
systems that can provide custom data, which are 
automatically collected, reducing logging effort of the user, 
but which promote concepts of ownership over one’s data 
generation and curation.  
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